Investing in National HIV PrEP Preparedness-Reference-Cited by-同舟云学术

Investing in National HIV PrEP Preparedness

Published:2023-03-02 Issue:9 Volume:388 Page:769-771
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Johnson Jeremiah¹,Killelea Amy¹,Farrow Kenyon¹

Affiliation:

1. From PrEP4All, New York (J.J., K.F.); Bloomberg School of Public Health, Johns Hopkins University, Baltimore (A.K.); and Killelea Consulting, Arlington, VA (A.K.).

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMp2216100

Reference3 articles.

1. Financing and Delivering Pre-Exposure Prophylaxis (PrEP) to End the HIV Epidemic

2. Associated Costs Are a Barrier to HIV Preexposure Prophylaxis Access in the United States

3. Comparative Pricing of Branded Tenofovir Alafenamide–Emtricitabine Relative to Generic Tenofovir Disoproxil Fumarate–Emtricitabine for HIV Preexposure Prophylaxis

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Equity of PrEP uptake by race, ethnicity, sex and region in the United States in the first decade of PrEP: a population-based analysis;The Lancet Regional Health - Americas;2024-05

2. “To do so in a patient-centred way is not particularly lucrative”: The effects of neoliberal health care on PrEP implementation and delivery;Social Science & Medicine;2024-04

3. Barriers and facilitators to pre-exposure prophylaxis uptake among Black/African American men who have sex with other men in Iowa: COM-B model analysis;Therapeutic Advances in Infectious Disease;2024-01

4. Health Ecosystem Resilience Strategies for Inclusive Development;Advances in Logistics, Operations, and Management Science;2023-12-01

5. Do Pandemics Ever End?;New England Journal of Medicine;2023-10-12